Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
5.05
-0.10 (-1.94%)
Feb 4, 2026, 4:00 PM EST - Market closed
Climb Bio Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$9.50
Upside
+88.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +117.82% | Dec 18, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 16, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +58.42% | Oct 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +78.22% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +58.42% | Sep 30, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +38.61% | Sep 22, 2025 |
| Baird | Baird | Buy Initiates $9 | Buy | Initiates | $9 | +78.22% | Aug 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +98.02% | Jun 6, 2025 |